Vox Markets Logo

Ncondezi Energy, Block Energy, Diaceutics and Chris Bailey on TED, ASC, IGG & PSN

12:45, 21st March 2019
Justin Waite
Daily Podcast with Justin Waite
TwitterFacebookLinkedIn

Vox Media Player

DYOR Disclaimer

If you find this podcast useful please give it a rating and review on iTunes by clicking here

Do you want to get instant company alerts to the front screen of your smartphone? Download the Vox Markets app here: www.VoxMarkets.co.uk/app


On today's Vox Markets Podcast: Ncondezi Energy, Block Energy, Diaceutics and Chris Bailey on TED, AST, IGG & PSN

Hanno Pengilly, Chief Development Officer at Ncondezi Energy (NCCL) FOLLOW provides an update on the joint development agreement.

Ncondezi owns 100% of the Ncondezi Project which is strategically located in the power generating hub of the country, the Tete Province in northern Mozambique. The Company is developing an integrated thermal coal mine and power plant in phases of 300MW up to 1,800MW. The first 300MW phase is targeting domestic consumption in Mozambique using reinforced existing transmission capacity to meet current demand.


Paul Haywood, Chief Executive Officer of Block Energy (BLOE) FOLLOW discusses their 16a well at West Rustavi where they encountered significant hydrocarbon shows.

Block Energy (BLOE.L) is an AIM quoted oil and gas company with a growing portfolio of production, development and exploration assets in the Republic of Georgia. Block holds a 100% WI in the producing Norio licence, a 90% WI in the producing Satskhenisi licence and a 71.5% WI in the West Rustavi licence, with an agreement to take a 100% WI. (Interview starts at 12 minutes 57 seconds)


Phillip White, Chief Financial Officer of Diaceutics (DXRX) FOLLOW talks about their business on the first day of listing as an AIM company.

Diaceutics has established a suite of data-driven products and implementation services powered by the data held in its proprietary database. Its products and services are focused on optimising its clients' strategies for the development and launch of precision medicines and specifically, the diagnostic testing required to guide selection of such medicines. The Company currently provides services to 20 of the 30 largest global pharmaceutical companies. (Interview starts at 19 minutes 20 seconds)


Chris Bailey founder of Financial Orbit covers:

Ted Baker (TED) FOLLOW

Asos (ASC) FOLLOW

IG Group (IGG) FOLLOW

Persimmon (PSN) FOLLOW

(Interview starts at 27 minutes 37 seconds)

TwitterFacebookLinkedIn

Disclaimer & Declaration of Interest

The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.

Recent Articles
Watchlist